Genetic variation at the human α2B-adrenergic receptor locus: Role in blood pressure variation and yohimbine response

Hypertension

Volumn 45, Issue 6, 2005, Pages 1207-1213

  Etzel, Jason P ^b   Rana, Brinda K ^b   Wen, Gen ^a   Farmer, Robert J ^a   Schork, Nicholas J ^b   O'Connor, Daniel T ^a,c,d   Insel, Paul A ^a,b,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d San Diego   (United States)

Author keywords

Haplotypes; Intermediate phenotype; Receptors, adrenergic alpha; SNP

Indexed keywords

ALPHA 2B ADRENERGIC RECEPTOR; DNA; YOHIMBINE;

ADRENERGIC SYSTEM; ARTICLE; BLOOD PRESSURE; DISEASE PREDISPOSITION; DRUG EFFECT; ESSENTIAL HYPERTENSION; ETHNIC GROUP; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE; RECEPTOR GENE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADRENERGIC ALPHA-ANTAGONISTS; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CHROMOSOME MAPPING; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, ALPHA-2; VARIATION (GENETICS); YOHIMBINE;

EID: 20044388350     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000166721.42734.49     Document Type: Article

References (31)

1. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev. 2001;53:319-356.
2. Michel MC, Daul A, Galal O, Wang XL, Brodde OE. Are alpha- and beta-adrenoceptor changes in patients with essential hypertension genetically determined? J Hypertens Suppl. 1988;6:S575-S577.
3. DiBona GF, Jones SY. Central alpha 2-adrenoceptor responsiveness in borderline hypertensive rats. J Hypertens. 1991;9:543-547.
4. Brede M, Philipp M, Knaus A, Muthig V, Hein L. alpha2-adrenergic receptor subtypes - novel functions uncovered in gene-targeted mouse models. Biol Cell. 2004;96:343-348.
5. Miller RJ. Presynaptic receptors. Annu Rev Pharmacol Toxicol. 1998;38: 201-227.
6. Hein L, Altman JD, Kobilka BK. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature. 1999;402:181-184.
7. Altman JD, Trendelenburg AU, MacMillan L, Bernstein D, Limbird L, Starke K, Kobilka BK, Hein L. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol. 1999;56:154-161.
8. Makaritsis KP, Handy DE, Johns C, Kobilka B, Gavras I, Gavras H. Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension. Hypertension. 1999;33:14-17.
9. Kintsurashvili E, Johns C, Ignjacev I, Gavras I, Gavras H. Central alpha2B-adrenergic receptor antisense in plasmid vector prolongs reversal of salt-dependent hypertension. J Hypertens. 2003;21:961-967.
10. Link RE, Desai K, Hein L, Stevens ME, Chruscinski A, Bernstein D, Barsh GS, Kobilka BK. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science. 1996;273:803-805.
11. Pettinger WA. Renal alpha 2-adrenergic receptors and hypertension. Hypertension. 1987;9:3-6.
12. Sripairojthikoon W, Wyss JM. High NaCl diets increase alpha 2-adrenoceptors in renal cortex and medulla of NaCl-sensitive spontaneously hypertensive rats. Eur J Pharmacol. 1989;167:355-365.
13. Kirstein SL, Insel PA. Autonomic nervous system pharmacogenomics: a progress report. Pharmacol Rev. 2004;56:31-52.
14. Small KM, Brown KM, Forbes SL, Liggett SB. Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem. 2001;276:4917-4922.
15. Snapir A, Heinonen P, Tuomainen TP, Alhopuro P, Karvonen MK, Lakka TA, Nyyssonen K, Salonen R, Kauhanen J, Valkonen VP, Pesonen U, Koulu M, Scheinin M, Salonen JT. An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol. 2001;37:1516-1522.
16. Snapir A, Mikkelsson J, Perola M, Penttila A, Scheinin M, Karhunen PJ. Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J Am Coll Cardiol. 2003;41:190-194.
17. Snapir A, Koskenvuo J, Toikka J, Orho-Melander M, Hinkka S, Saraste M, Hartiala J, Scheinin M. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline. Clin Sci (Lond). 2003;104:509-520.
18. Heinonen P, Jartti L, Jarvisalo MJ, Pesonen U, Kaprio JA, Ronnemaa T, Raitakari OT, Scheinin M. Deletion polymorphism in the alpha2B-adrenergic receptor gene is associated with flow-mediated dilatation of the brachial artery. Clin Sci (Lond). 2002;103:517-524.
19. Sivenius K, Lindi V, Niskanen L, Laakso M, Uusitupa M. Effect of a three-amino acid deletion in the alpha2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects. Int J Obes Relat Metab Disord. 2001;25:1609-1614.
20. Baldwin CT, Schwartz F, Baima J, Burzstyn M, DeStefano AL, Gavras I, Handy DE, Joost O, Martel T, Manolis A, Nicolaou M, Bresnahan M, Fairer L, Gavras H. Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertension. Am J Hypertens. 1999;12:853-857.
21. Von Wowern F, Bengtsson K, Lindblad U, Rastam L, Melander O. Functional variant in the (alpha)2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension. Hypertension. 2004;43:592-597.
22. Small KM, Forbes SL, Rahman FF, Bridges KM, Liggett SB. A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors. J Biol Chem. 2000;275:23059-23064.
23. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med. 2002;347:1135-1142.
24. Dao TT, Kailasam MT, Parmer RJ, Le HV, Le Verge R, Kennedy BP, Ziegler G, Insel PA, Wright FA, O'Connor DT. Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension. J Hypertens. 1998;16: 779-792.
25. Goldstein DS, Grossman E, Listwak S, Folio CJ. Sympathetic reactivity during a yohimbine challenge test in essential hypertension. Hypertension. 1991;18:III40-III48.
26. O'Connor DT, Insel PA, Ziegler MG, Hook VY, Smith DW, Hamilton BA, Taylor PW, Parmer RJ. Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep. 2000;2:16-22.
27. Le Corre P, Parmer RJ, Kailasam MT, Kennedy BP, Skaar TP, Ho H, Leverge R, Smith DW, Ziegler MG, Insel PA, Schork NJ, Flockhart DA, O'Connor DT. Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism. Clin Pharmacol Ther. 2004;76: 139-153.
28. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545-556.
29. King D, Etzel JP, Chopra S, Smith J, Cadman PE, Rao F, Funk SD, Rana BK, Schork NJ, Insel PA, O'Connor DT. Human response to a2-adrenergic agonist stimulation studies in an isolated vascular bed in vivo: biphasic influence of dose, age, gender, and receptor genotype. Clin Pharmacol Ther. In press.
30. Halperin E, Eskin E. Haplotype reconstruction from genotype data using imperfect phylogeny. Bioinformatics. 2004;20:1842-1849.
31. Cayla C, Heinonen P, Viikari L, Schaak S, Snapir A, Bouloumie A, Karvonen MK, Pesonen U, Scheinin M, Paris H. Cloning, characterisation and identification of several polymorphisms in the promoter region of the human alpha2B-adrenergic receptor gene. Biochem Pharmacol. 2004;67:469-478.